Hepion Pharmaceuticals, Inc.(HEPA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HEPA Hepion Pharmaceuticals, Inc.

休市中 05-31 16:00:00 EDT

1.26

+0.02

+1.61%

盘后1.26

+0.000.00%

16:01 EDT

最高1.29	最低1.23	成交量1.63万
今开1.27	昨收1.24	日振幅5.24%
总市值689.53万	流通市值632.38万	总股本547.25万
成交额2.07万	换手率0.32%	流通股本501.89万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"HEPA","market":"US","secType":"STK","nameCN":"Hepion Pharmaceuticals, Inc.","latestPrice":1.26,"timestamp":1717185600000,"preClose":1.24,"halted":0,"volume":16270,"hourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"16:01 EDT","volume":15,"amount":18.9,"timestamp":1717185713769},"delay":0,"floatShares":5018864,"shares":5472451,"eps":-8.987243,"marketStatus":"休市中","marketStatusCode":7,"change":0.02,"latestTime":"05-31 16:00:00 EDT","open":1.27,"high":1.29,"low":1.225,"amount":20667.305916,"amplitude":0.052419,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-8.987243,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717401600000},"adr":0,"adjPreClose":1.24,"postHourTrading":{"tag":"盘后","latestPrice":1.26,"preClose":1.26,"latestTime":"16:01 EDT","volume":15,"amount":18.9,"timestamp":1717185713769},"volumeRatio":0.44737623795851805},"requestUrl":"/m/hq/s/HEPA","defaultTab":"news","newsList":[{"id":"2439288836","title":"Hepion Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439288836","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2439288836?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:54","pubTimestamp":1717077250,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时54分，Hepion Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.00%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Kintara Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃，换手率分别为66.74%、31.21%、28.36%，振幅较大的相关个股有Kintara Therapeutics, Inc.、Onconetix, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为34.78%、23.74%、20.65%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要致力于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053021541096810d5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024053021541096810d5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2438058065","title":"Hepion Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438058065","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2438058065?lang=zh_cn&edition=full","pubTime":"2024-05-25 01:39","pubTimestamp":1716572361,"startTime":"0","endTime":"0","summary":"北京时间2024年05月25日01时39分，Hepion Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.26%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Onconetix, Inc.、Verastem, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为148.91%、59.31%、36.07%，振幅较大的相关个股有Onconetix, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cns Pharmaceuticals, Inc.，振幅分别为104.53%、57.38%、52.28%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要致力于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525013921af8a312b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240525013921af8a312b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2437479799","title":"Hepion Pharmaceuticals(HEPA.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.56美元，前值为-3.4美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2437479799","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2437479799?lang=zh_cn&edition=full","pubTime":"2024-05-22 05:45","pubTimestamp":1716327921,"startTime":"0","endTime":"0","summary":"Hepion Pharmaceuticals(HEPA.US)：2024年Q1财报实现营收0美元，前值为0美元；每股收益为-0.56美元，前值为-3.4美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405220545268b218922&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405220545268b218922&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435854318","title":"Hepion Pharmaceuticals, Inc.盘中异动 快速拉升6.61%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435854318","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435854318?lang=zh_cn&edition=full","pubTime":"2024-05-15 00:04","pubTimestamp":1715702647,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日00时04分，Hepion Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.61%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Humacyte Inc C/Wts 27/08/2026 、Prokidney Corp.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为117.55%、55.00%、24.71%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为69.43%、65.80%、53.25%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要致力于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515000407861ed22c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240515000407861ed22c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435037760","title":"Hepion Pharmaceuticals, Inc.盘中异动 临近午盘大幅下挫6.35%报1.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435037760","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435037760?lang=zh_cn&edition=full","pubTime":"2024-05-13 23:49","pubTimestamp":1715615376,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日23时49分，Hepion Pharmaceuticals, Inc.股票出现波动，股价快速跳水6.35%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，诺瓦瓦克斯医药、Estrella Immunopharma Inc C/Wts 29/09/2028、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为77.14%、56.04%、54.37%，振幅较大的相关个股有诺瓦瓦克斯医药、Tevogen Bio Holdings Inc.、Oragenics Inc.，振幅分别为50.11%、45.71%、38.27%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要致力于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513234936792763e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513234936792763e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433721343","title":"Hepion Pharmaceuticals, Inc.股价拉升13.13% 市值涨111.37万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433721343","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433721343?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:38","pubTimestamp":1715175484,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时38分，Hepion Pharmaceuticals, Inc.股票出现异动，股价大幅上涨13.13%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Effector Therapeutics Inc C/Wts 31/12/2025 、Adaptive Biotechnologies Corporation、Repare Therapeutics Inc.涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为207.78%、31.42%、12.97%，振幅较大的相关个股有Adaptive Biotechnologies Corporation、Y-Mabs Therapeutics, Inc.、Transcode Therapeutics, Inc.，振幅分别为15.79%、14.76%、11.91%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要致力于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213805861ebc72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240508213805861ebc72&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433884047","title":"Hepion Pharmaceuticals, Inc.盘中异动 大幅跳水5.79%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433884047","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433884047?lang=zh_cn&edition=full","pubTime":"2024-05-07 21:54","pubTimestamp":1715090041,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日21时54分，Hepion Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.79%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.54%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Clearmind Medicine Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为1268.29%、137.76%、66.80%，振幅较大的相关个股有Tc Biopharm  Plc、Clearmind Medicine Inc.、Corvus Pharmaceuticals, Inc.，振幅分别为31.03%、29.06%、26.70%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要致力于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072154018ae530f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072154018ae530f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433408379","title":"Hepion Pharmaceuticals, Inc.盘中异动 大幅拉升5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433408379","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433408379?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:52","pubTimestamp":1715007155,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时52分，Hepion Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.48%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Nrx Pharmaceuticals, Inc.、Tc Biopharm  Plc、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1087.65%、713.78%、67.05%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、84.25%、40.00%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要致力于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622523579260f63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050622523579260f63&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432601116","title":"Hepion Pharmaceuticals, Inc.盘中异动 股价大涨6.62%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432601116","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432601116?lang=zh_cn&edition=full","pubTime":"2024-05-02 21:45","pubTimestamp":1714657505,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日21时45分，Hepion Pharmaceuticals, Inc.股票出现波动，股价快速上涨6.62%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。其相关个股中，Allarity Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Aptevo Therapeutics Inc.涨幅较大，Allarity Therapeutics, Inc.、Aptevo Therapeutics Inc.、Context Therapeutics Inc.较为活跃，换手率分别为2249.03%、354.22%、97.66%，振幅较大的相关个股有Allarity Therapeutics, Inc.、Fresh2 Group Limited、Aptevo Therapeutics Inc.，振幅分别为65.69%、24.08%、23.96%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要专注于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221450687cb1b3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050221450687cb1b3e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431869528","title":"Hepion Pharmaceuticals, Inc.盘中异动 大幅拉升5.10%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431869528","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431869528?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:43","pubTimestamp":1714398232,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时43分，Hepion Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.10%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Immunitybio, Inc.、Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为613.79%、27.35%、14.25%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Immunitybio, Inc.、Eliem Therapeutics, Inc，振幅分别为33.33%、20.84%、18.59%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要专注于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292143527a5729a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292143527a5729a3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429197100","title":"Hepion Pharmaceuticals, Inc.盘中异动 早盘急速下跌8.51%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429197100","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429197100?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:32","pubTimestamp":1713879130,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时32分，Hepion Pharmaceuticals, Inc.股票出现异动，股价急速下跌8.51%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Palisade Bio, Inc.、Immunitybio, Inc.、Azitra Inc涨幅较大，Palisade Bio, Inc.、Silo Pharma, Inc.、Nkgen Biotech, Inc.较为活跃，换手率分别为455.00%、154.15%、21.25%，振幅较大的相关个股有Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Metagenomi, Inc.，振幅分别为15.21%、10.78%、9.28%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要专注于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232132117a54ec7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232132117a54ec7b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429914921","title":"Hepion Pharmaceuticals, Inc.盘中异动 大幅下挫37.81%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429914921","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429914921?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:32","pubTimestamp":1713792725,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时32分，Hepion Pharmaceuticals, Inc.股票出现波动，股价快速下挫37.81%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Moolec Science Sa C/Wts 、Moolec Science Sa、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Moolec Science Sa、Adial Pharmaceuticals, Inc、亚狮康药业较为活跃，换手率分别为88.19%、44.48%、33.34%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Nkgen Biotech, Inc.，振幅分别为86.63%、20.71%、15.37%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要专注于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132058b464edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222132058b464edb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428694788","title":"BUZZ-Hepion 停止脂肪肝治疗试验后股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2428694788","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428694788?lang=zh_cn&edition=full","pubTime":"2024-04-20 05:34","pubTimestamp":1713562448,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    4月19日 - ** 药物开发商Hepion Pharmaceuticals   的股票在延时交易中下跌33.8%，至1.30美元** 该公司称其正在停止 (link) 一项中期试验，该试验评估药物 rencofilstat 用于治疗一种被称为非酒精性脂肪性肝炎的脂肪肝疾病。** 鉴于目前的现金资源，产生相关疗效数据的可能性很低 - Hepion** 公司正在继续探索其他战略选择** 截至上次收盘，股价在过去 12 个月下跌了 86.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428665389","title":"Hepion Pharmaceuticals Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2428665389","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428665389?lang=zh_cn&edition=full","pubTime":"2024-04-17 06:15","pubTimestamp":1713305754,"startTime":"0","endTime":"0","summary":"   * Hepion Pharmaceuticals Inc   报告了截至12月底的季度调整后每股亏损2.42美元，高于去年同期的每股亏损2.60美元。两位分析师对该季度的平均预期为每股亏损 2.63 美元。* Hepion Pharmaceuticals Inc 报告的本季度每股收益为亏损 2.42 美元。* 该公司一季度亏损 1106 万美元。* Hepion Pharmaceuticals Inc 本季度股价下跌了 12.4%，今年迄今为止下跌了 32.7%。* 华尔街对 Hepion Pharmaceuticals Inc 的 12 个月目标价中位数为 26.00 美元。本摘要由 LSEG 4 月 16 日 10:15 p.m. UTC 数据机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428880257","title":"Hepion Pharmaceuticals, Inc.盘中异动 临近收盘大幅下跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428880257","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428880257?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:33","pubTimestamp":1713295998,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时33分，Hepion Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.50%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、Jaguar Health, Inc.、Finch Therapeutics Group, Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为3335.12%、269.98%、212.24%，振幅较大的相关个股有Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.，振幅分别为103.61%、101.94%、97.81%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要专注于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417033319861e65ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417033319861e65ef&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427549750","title":"Hepion Pharmaceuticals Inc    预计每股亏损 2.63 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2427549750","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427549750?lang=zh_cn&edition=full","pubTime":"2024-04-13 04:30","pubTimestamp":1712953817,"startTime":"0","endTime":"0","summary":"   * Hepion Pharmaceuticals Inc    预计将于4月15日公布截至2023年12月31日的财报(预计)    *    * LSEG 的分析师平均预计 Hepion Pharmaceuticals Inc 每股亏损 2.63 美元。* 华尔街对 Hepion Pharmaceuticals Inc 的 12 个月目标价中位数为 26.00 美元，高于其上一次收盘价 2.23 美元。4月12日 - 本摘要于北京时间 4 月 12 日 20:30 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426261130","title":"Hepion Pharmaceuticals, Inc.盘中异动 快速跳水6.57%报2.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426261130","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426261130?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:27","pubTimestamp":1712849221,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时27分，Hepion Pharmaceuticals, Inc.股票出现波动，股价快速跳水6.57%。Hepion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Leap Therapeutics, Inc.涨幅较大，Adial Pharmaceuticals, Inc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃，换手率分别为656.64%、487.72%、473.86%，振幅较大的相关个股有Rallybio Corporation、Tc Biopharm  Plc C/Wts 10/02/2028 、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为50.92%、46.31%、40.90%。Hepion Pharmaceuticals, Inc.公司简介：Hepion Pharmaceuticals Inc 是一家生物制药公司，主要专注于开发治疗慢性肝病的药物疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411232701791ff456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411232701791ff456&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hepion.com","stockEarnings":[{"period":"1week","weight":0.1251},{"period":"1month","weight":-0.0735},{"period":"3month","weight":-0.6025},{"period":"6month","weight":-0.6294},{"period":"1year","weight":-0.8671},{"period":"ytd","weight":-0.6111}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Hepion Pharmaceuticals, Inc.于2013年5月15日根据特拉华州法律注册成立。该公司是一家生物制药公司，总部位于新泽西州爱迪生，主要专注于开发治疗慢性纤维化相关疾病的药物疗法。主要的治疗方法专门针对与纤维化以及炎症相关的疾病机制，并显示出治疗非酒精性脂肪性肝炎、肝细胞癌、病毒性肝炎和其他纤维化疾病的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.057057},{"month":2,"riseRate":0.333333,"avgChangeRate":0.001389},{"month":3,"riseRate":0.3,"avgChangeRate":-0.039711},{"month":4,"riseRate":0.3,"avgChangeRate":-0.189269},{"month":5,"riseRate":0.2,"avgChangeRate":0.516759},{"month":6,"riseRate":0.555556,"avgChangeRate":0.037838},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.100304},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.039168},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.152515},{"month":10,"riseRate":0.333333,"avgChangeRate":0.066232},{"month":11,"riseRate":0.333333,"avgChangeRate":0.055144},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.179013}],"exchange":"NASDAQ","name":"Hepion Pharmaceuticals, Inc.","nameEN":"Hepion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hepion Pharmaceuticals, Inc.(HEPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hepion Pharmaceuticals, Inc.(HEPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hepion Pharmaceuticals, Inc.,HEPA,Hepion Pharmaceuticals, Inc.股票,Hepion Pharmaceuticals, Inc.股票老虎,Hepion Pharmaceuticals, Inc.股票老虎国际,Hepion Pharmaceuticals, Inc.行情,Hepion Pharmaceuticals, Inc.股票行情,Hepion Pharmaceuticals, Inc.股价,Hepion Pharmaceuticals, Inc.股市,Hepion Pharmaceuticals, Inc.股票价格,Hepion Pharmaceuticals, Inc.股票交易,Hepion Pharmaceuticals, Inc.股票购买,Hepion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hepion Pharmaceuticals, Inc.(HEPA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hepion Pharmaceuticals, Inc.(HEPA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况